The FDA has refused to accept an application for a proposed treatment of atrial fibrillation. The approval of Cardiome's new treatment for atrial fibrillation is set to be delayed by almost a year after the FDA refused to file an application for the drug.
Pharmaceutical Business Review
Simplifying Global Compliance
Recommended Products
EU MDR Compliance: A Checklist for Meeting Manufacturing, Safety and Performance Requirements
The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.
Accelerating Generic Drug Development: The FDA’s New Plan for Increasing Generic Competition
Accelerating Generic Drug Development explains the FDA’s new policy and shows how to navigate the new pathway to approval.
Editor's Picks
Brightwater’s Biliary Stent System Cleared by FDA
The stent system helps to treat biliary duct obstructions, which can lead to serious complications.
FDA Issues Warning Over Paclitaxel-Coated Balloons, Stents
Paclitaxel is used in the treatment of breast, lung and ovarian cancer, as well as Kaposi's sarcoma.
FDAnews Drug Daily Bulletin
CARDIOME/ASTELLAS: FDA SETBACK FOR HEART DRUG
June 5, 2006
